CellMax Life
After years of research and clinical testing, we have developed non-invasive, accurate blood tests for early detection of cancer. By making cancer prevention routine, we enable everyone to take control of their own health. The more people take our breakthrough blood tests, the more lives we can save. Life over cancer.

CellMax Life

  • Publications
  • News Center
  • Company
  • Contact

Novel Blood Based Circulating Tumor Cell Biomarker For Breast Cancer Detection

  • 0
Stephen Su
Tuesday, 01 October 2019 / Published in Publications and Abstracts

Novel circulating tumor cell‑based blood test for the assessment of PD‑L1 protein expression in treatment‑naïve, newly diagnosed patients with non‑small cell lung cancer

  • 0
Stephen Su
Friday, 31 May 2019 / Published in Publications and Abstracts

Prospective Clinical Study of Circulating Tumor Cells For Colorectal Cancer Screening

  • 0
Stephen Su
Thursday, 03 January 2019 / Published in Publications and Abstracts

Antibody conjugated supported lipid bilayer for capturing and purification of viable tumor cells in blood for subsequent cell culture.

  • 0
Stephen Su
Thursday, 03 January 2019 / Published in Publications and Abstracts

CTC and ctDNA Profiling to Detect 6 NCCN-Guideline Recommended Classes of Alterations For Immunotherapy and Targeted Therapy Selection Using Sample From a Single Blood Draw

  • 0
Stephen Su
Thursday, 03 January 2019 / Published in Publications and Abstracts

Analytical validation of a novel circulating tumor DNA detection platform for targeted and immunotherapy selection

  • 0
Stephen Su
Thursday, 03 January 2019 / Published in Publications and Abstracts

Comparison of rare pathogenic germline variants associated with cancer predisposition syndrome in Taiwan and USA populations

  • 0
Stephen Su
Thursday, 03 January 2019 / Published in Publications and Abstracts

Prospective Clinical Study of a Prostate Cancer (PCa) Rule-Out Blood Test for PSA Gray Zone Patients Using a Sensitive Circulating Tumor Cell Assay

  • 0
Stephen Su
Thursday, 03 January 2019 / Published in Publications and Abstracts

CSF-ctDNA SMSEQ Analysis to Tailor the Treatment of a Patient with Brain Metastases: A Case Report

  • 0
Stephen Su
Thursday, 03 January 2019 / Published in Publications and Abstracts

Liquid Biopsy Prevents Inaccurate Her2 Status Determination by in situ Hybridization in a Patient with Invasive Ductal Adenocarcinoma of the Breast: Case Report

  • 0
Stephen Su
Thursday, 03 January 2019 / Published in Publications and Abstracts
  • 1
  • 2
  • 3
  • 4

Education

  • Publications
  • News Center
  • Company
  • Contact

U.S. Headquarters

1271 Oakmead Parkway Sunnyvale, CA 94085
Phone: +1 650-564-3905

Taiwan Office

28F.-5, No. 97, Sec. 1, Xintai 5th Rd.
Xizhi Dist., New Taipei City 221, Taiwan
+886-2-26971377 (Taiwan)

  • © 2023 CellMax Life
  • All Rights Reserved
  • Terms and Conditions
  • Privacy Policy
TOP